Sfoglia per Titolo
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients
2011-01-01 Silvia De Francia; Francesca De Martino; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients
2011-01-01 Silvia De Francia; Francesca De Martino; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients
2011-01-01 Francesca De Martino; Silvia De Francia; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS
2014-01-01 Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G
Pharmacogenetic of voriconazole antifungal agent in pediatric patients
2018-01-01 Allegra, Sarah; Fatiguso, Giovanna; Francia, Silvia De; Pirro, Elisa; Carcieri, Chiara; Cusato, Jessica; Nicolò, Amedeo De; Avataneo, Valeria; Perri, Giovanni Di; D'Avolio, Antonio
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis
2021-01-01 Cusato, J; Calcagno, A; Antonucci, M; Marinaro, L; Avataneo, V; De Nicolò, Amedeo; Bonora, S; Di Perri, G; D'avolio, A
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol
2017-01-01 Franca, R.*; Rebora, P.; Bertorello, N.; Fagioli, F.; Conter, V.; Biondi, A.; Colombini, A.; Micalizzi, C.; Zecca, M.; Parasole, R.; Petruzziello, F.; Basso, G.; Putti, M.C.; Locatelli, F.; D'Adamo, P.; Valsecchi, M.G.; Decorti, G.; Rabusin, M.
Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: Focus on p53
2008-01-01 Lanni C.; Racchi M.; Uberti D.; Mazzini G.; Stanga S.; Memo M.; Memo E.; Govoni S.
Pharmacogenetics as a tool to tailor the immunosuppressive therapy: focus on azathioprine and tacrolimus
2016-01-01 Serpe, Loredana; Calvo, Pier Luigi; Brunati, Andrea; Amoroso, Antonio; Romagnoli, Renato; Canaparo, Roberto
Pharmacogenetics of Antiretrovirals' Penetrations into Cerebrospinal Fluid
2016-01-01 Scaviglieri, E.; Cusato, J.; Audagnotto, S.; Lipani, F.; Cardellino, C.; Cecilia, C.; D'Avolio, A.; Bonora, S.; Di Perri, G.; Calcagno, A.
Pharmacogenetics of drug-metabolizing enzymes in Italian populations
2015-01-01 Serpe L; Canaparo R; Scordo MG; Spina E
Pharmacogenetics of methylphenidate response in preschoolers with ADHD
2006-01-01 Mcgough, James; Mccracken, James; Swanson, James; Riddle, Mark; Kollins, Scott; Greenhill, Laurence; Abikoff, Howard; Davies, Mark; Chuang, Shirley; Wigal, Tim; Wigal, Sharon; Posner, Kelly; Skrobala, Anne; Kastelic, Elizabeth; Ghuman, Jaswinder; Cunningham, Charles; Shigawa, Sharon; Moyzis, Robert; Vitiello, Benedetto
Pharmacogenetics of ribavirin-induced anemia in HCV patients
2016-01-01 D'Avolio, Antonio; Cusato, Jessica; De Nicolò, Amedeo; Allegra, Sarah; Di Perri, Giovanni
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study
2018-01-01 Cusato, Jessica; De Nicolò, Amedeo; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Carcieri, Chiara; Guido, Federica; Avataneo, Valeria; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy
2005-01-01 Giachino, Daniela Francesca; Ghio, P.; Regazzoni, S.; Mandrile, Giorgia; Novello, Silvia; Selvaggi, G.; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio
Pharmacogenetics studies in patients with advanced lungcancer: prognostic value of the thymidylate synthase 2R/3Rpolymorphism and predictivity of NER factor XPD K751Qand XRCC1 R399Q polymorphisms following platinum-basedchemotherapy
2005-01-01 Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; SelvaggiG; De Marchi; Scagliotti GV
Pharmacogenetics-based Schedule Adjustment of Unboosted Atazanavir Associated with Tenofovir/Emtricitabine: A Randomized Controlled Study (REYAGEN)
2013-01-01 S Bonora; O Vigano; A Calcagno; J Cusato; M Lanzafame; A Trentalange; A D’Avolio; M Galli; S Rusconi; G Di Perri
Pharmacogenetics-based Schedule Adjustment of Unboosted Atazanavir-based Regimens: 48 Weeks Results of Reyagen a Randomized and Controlled Pilot Study - PE10/14
2013-01-01 L. Marinaro; O. Viganò; A. Calcagno; V. Di Cristo; J. Cusato; M. Lanzafame; A. Trentalange; A. D'Avolio; M. Galli; G. Di Perri; S. Rusconi; S. Bonora
Pharmacogenomic influence on sepsis outcome in critically ill patients
2017-01-01 Allegra, Sarah; Fatiguso, Giovanna; Baietto, Lorena; Corcione, Silvia; Favata, Fabio; Ariaudo, Alessandra; Pagani, Nicole; Ranieri, Vito Marco; De Rosa, Francesco Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
2002-01-01 Sarries, Carme; Haura, Eric B.; Roig, Barbara; Taron, Miquel; Abad, Albert; Scagliotti, Giorgio; Rosell, Rafael*
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients | 2011 | Silvia De Francia; Francesca De Martino; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo | |
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients | 2011 | Silvia De Francia; Francesca De Martino; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo | |
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients | 2011 | Francesca De Martino; Silvia De Francia; Antonio D'Avolio; Elisa Pirro; Francesca Piccione; Jessica Cusato; Alfredo Berruti; Massimo Terzolo; Francesco Di Carlo | |
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS | 2014 | Fava C; Cusato J; Ariaudo A; D'Avolio A; De Francia S; Giugliano E; Rege-Cambrin G; Saglio G | |
Pharmacogenetic of voriconazole antifungal agent in pediatric patients | 2018 | Allegra, Sarah; Fatiguso, Giovanna; Francia, Silvia De; Pirro, Elisa; Carcieri, Chiara; Cusato, Jessica; Nicolò, Amedeo De; Avataneo, Valeria; Perri, Giovanni Di; D'Avolio, Antonio | |
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis | 2021 | Cusato, J; Calcagno, A; Antonucci, M; Marinaro, L; Avataneo, V; De Nicolò, Amedeo; Bonora, S; Di Perri, G; D'avolio, A | |
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol | 2017 | Franca, R.*; Rebora, P.; Bertorello, N.; Fagioli, F.; Conter, V.; Biondi, A.; Colombini, A.; Micalizzi, C.; Zecca, M.; Parasole, R.; Petruzziello, F.; Basso, G.; Putti, M.C.; Locatelli, F.; D'Adamo, P.; Valsecchi, M.G.; Decorti, G.; Rabusin, M. | |
Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: Focus on p53 | 2008 | Lanni C.; Racchi M.; Uberti D.; Mazzini G.; Stanga S.; Memo M.; Memo E.; Govoni S. | |
Pharmacogenetics as a tool to tailor the immunosuppressive therapy: focus on azathioprine and tacrolimus | 2016 | Serpe, Loredana; Calvo, Pier Luigi; Brunati, Andrea; Amoroso, Antonio; Romagnoli, Renato; Canaparo, Roberto | |
Pharmacogenetics of Antiretrovirals' Penetrations into Cerebrospinal Fluid | 2016 | Scaviglieri, E.; Cusato, J.; Audagnotto, S.; Lipani, F.; Cardellino, C.; Cecilia, C.; D'Avolio, A.; Bonora, S.; Di Perri, G.; Calcagno, A. | |
Pharmacogenetics of drug-metabolizing enzymes in Italian populations | 2015 | Serpe L; Canaparo R; Scordo MG; Spina E | |
Pharmacogenetics of methylphenidate response in preschoolers with ADHD | 2006 | Mcgough, James; Mccracken, James; Swanson, James; Riddle, Mark; Kollins, Scott; Greenhill, Laurence; Abikoff, Howard; Davies, Mark; Chuang, Shirley; Wigal, Tim; Wigal, Sharon; Posner, Kelly; Skrobala, Anne; Kastelic, Elizabeth; Ghuman, Jaswinder; Cunningham, Charles; Shigawa, Sharon; Moyzis, Robert; Vitiello, Benedetto | |
Pharmacogenetics of ribavirin-induced anemia in HCV patients | 2016 | D'Avolio, Antonio; Cusato, Jessica; De Nicolò, Amedeo; Allegra, Sarah; Di Perri, Giovanni | |
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study | 2018 | Cusato, Jessica; De Nicolò, Amedeo; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Carcieri, Chiara; Guido, Federica; Avataneo, Valeria; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio | |
Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy | 2005 | Giachino, Daniela Francesca; Ghio, P.; Regazzoni, S.; Mandrile, Giorgia; Novello, Silvia; Selvaggi, G.; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio | |
Pharmacogenetics studies in patients with advanced lungcancer: prognostic value of the thymidylate synthase 2R/3Rpolymorphism and predictivity of NER factor XPD K751Qand XRCC1 R399Q polymorphisms following platinum-basedchemotherapy | 2005 | Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; SelvaggiG; De Marchi; Scagliotti GV | |
Pharmacogenetics-based Schedule Adjustment of Unboosted Atazanavir Associated with Tenofovir/Emtricitabine: A Randomized Controlled Study (REYAGEN) | 2013 | S Bonora; O Vigano; A Calcagno; J Cusato; M Lanzafame; A Trentalange; A D’Avolio; M Galli; S Rusconi; G Di Perri | |
Pharmacogenetics-based Schedule Adjustment of Unboosted Atazanavir-based Regimens: 48 Weeks Results of Reyagen a Randomized and Controlled Pilot Study - PE10/14 | 2013 | L. Marinaro; O. Viganò; A. Calcagno; V. Di Cristo; J. Cusato; M. Lanzafame; A. Trentalange; A. D'Avolio; M. Galli; G. Di Perri; S. Rusconi; S. Bonora | |
Pharmacogenomic influence on sepsis outcome in critically ill patients | 2017 | Allegra, Sarah; Fatiguso, Giovanna; Baietto, Lorena; Corcione, Silvia; Favata, Fabio; Ariaudo, Alessandra; Pagani, Nicole; Ranieri, Vito Marco; De Rosa, Francesco Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio | |
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer | 2002 | Sarries, Carme; Haura, Eric B.; Roig, Barbara; Taron, Miquel; Abad, Albert; Scagliotti, Giorgio; Rosell, Rafael* |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile